Glutamate is an excitatory neurotransmitter in the mammalian central n
ervous system and a neurotoxin (excitotoxin) that has the potential to
destroy neurones by activation of ionotropic receptors. In contrast t
o the well documented role of glutamate in the pathogenesis of neurona
l degeneration resulting from hypoxia/ischaemia, hypoglycaemia, status
epilepticus and trauma, it has been difficult to establish a link bet
ween the excitotoxicity and neuronal death that occur in chronic neuro
degenerative disorders. Impairment of energy metabolism has been shown
to increase neuronal vulnerability to glutamate. The cause of this ph
enomenon lies in the attenuation of the Mg2+ blockade of the N-methyl-
D-aspartate receptors that leads to persistent activation of these rec
eptors by physiologic extracellular glutamate concentrations. The conc
ept of increased neuronal vulnerability to excitotoxic injury establis
hes a link between slow neuronal degeneration and excitotoxicity and s
uggests that glutamate antagonists may prove beneficial in the treatme
nt of chronic neurodegenerative diseases that have been resistant to t
herapy.